The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
Open accessAbstract
Background Current guidelines advocate a step-wise approach to disease-modifying treatment of primary biliary cholangitis (PBC): all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy – and those with inadequate biochemical response to UDCA are subsequently considered for second-line therapies, the conventional period to demonstrate inadequate UDCA response being 12 months. A potential limitation with this approach, however, is that patients at highest risk end up waiting longest for effective treatment. In this study, we sought to determine whether UDCA response can be accurately predicted using pre-treatment clinical parameters, so that alternative approaches to treatment stratification might be explored. Methods We undertook logistic regression analysis of pre-treatment variables in 2,703 UDCA-treated patients to derive the best-fitting model of UDCA response, defined as ALPT12 < 1.67×ULN. We validated the model in an external PBC cohort from Italy (n=460). Finally, we explored the biological plausibility of the model by looking for correlation between model predictions and key histological features on PBC liver biopsies (n = 20), such as biliary injury and fibrosis. Findings The following pre-treatment parameters were associated with lower probability of UDCA response: higher ALP (p<0.0001), higher bilirubin (p=0.0003), lower transaminases (TA, p=0.0012), younger age (p<0.0001), longer interval from diagnosis to the start of UDCA (treatment time lag, p<0.0001), and worsening of ALP from diagnosis (ΔALP, p<0.0001). Based on these variables, we derived a predictive score of UDCA response: UDCAresponsescore(URS)=0.77+0.60×(TBdiag)−1−2.73×ln(ALPdiag)+0.35×ln(TAdiag)+0.03×age−0.15×(treatmenttimelag)−0.56×ΔALP In external validation, the AUROC was 0.83 (0.79-0.87). In PBC liver biopsies, the URS was associated with ductular reaction (DR) and intermediate hepatocytes (IH). Interpretation We have derived and externally validated a model based on pre-treatment variables that accurately predicts UDCA response. Association with DR and IH provides face validity. Thus, this model provides a basis to explore alternative approaches to treatment stratification in PBC. Fundings Medical Research Council (MR/L001489/1); University of Milan-Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At a population level, UDCA improves serum liver biochemical markers, delays liver transplantation and increases life expectancy.21013”
From Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“UK-PBC studies have demonstrated that therapy delay in PBC leads to a significantly reduced likelihood that the therapy will work when eventually used.10”
From Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“studies from UK-PBC have clearly shown that UDCA treatment failure can be accurately predicted by pretreatment clinical parameters including the patient’s age and serum biochemistry.10”
The cited source says what the claim attributes to it.
In the citing paper
“It is clear, however, that the likelihood of response to UDCA can be predicted with accuracy at the outset of disease, and algorithms developed to allow prediction in practice.10”
The cited source says what the claim attributes to it.
In the citing paper
“A predictive model of response to ursodeoxycholic acid treatment was developed based on pretreatment clinical factors and biochemistries, 121 and was validated in other cohorts.122,123”
From Primary biliary cholangitis. (2024) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histological grading and staging of chronic hepatitis.
Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationA Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
Corpechot, C., Chazouillères, O., Rousseau, A., Le Gruyer, A., Habersetzer, F., Mathurin, P., Goria, O., Potier, P., Minello, A., Silvain, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714519 · Cited by 642
Lammers, W. J., van Buuren, H. R., Hirschfield, G. M., Janssen, H. L. A., Invernizzi, P., Mason, A. L., Ponsioen, C. Y., Floreani, A., Corpechot, C., Mayo, M. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.029 · Cited by 498
Self-citationUrsodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Hepatic progenitor cells of biliary origin with liver repopulation capacity
Lu, W.-Y., Bird, T. G., Boulter, L., Tsuchiya, A., Cole, A. M., Hay, T., Guest, R. V., Wojtacha, D., Man, T. Y., Mackinnon, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3203 · Cited by 479
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Liu, X., Invernizzi, P., Lu, Y., Kosoy, R., Lu, Y., Bianchi, I., Podda, M., Xu, C., Xie, G., Macciardi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.627 · Cited by 398
Self-citation
Cited by
Sorted by citations
Items 101–155 of 155
Clinical Trials in PBC Going Forward
Corpechot, C. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1687852 · Cited by 5
Gerussi, A., Carbone, M., & Invernizzi, P. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15095 · Cited by 4
Self-citationCançado, G. G. L., Chen, B., Cameron, M., Houri, I., Leung, K. K., Gulamhusein, A. F., Hansen, B. E., & Hirschfield, G. M. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000798 · Cited by 6
Self-citationDíaz‐González, Á., Molera, C., Domínguez, E. G., Muñoz‐Bartolo, G., Ampuero, J., Fernández‐Rodríguez, C., Quintero, J., Molina, E., Salcedo, M., Olveira, A., et al. (2025) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2026.502629 · Cited by 3
Mandea, M., Iacob, S. M., Ghioca, M. C., Gheorghe, C., & Gheorghe, L. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228240 · Cited by 3
Chen, Z., Song, W., & Lin, W. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.112832 · Cited by 3
Gerussi, A., Nofit, E., Bernasconi, D. P., Kroll, C., Groß, F., Schregel, I., Marini, A., Cristoferi, L., Malinverno, F., Papp, M., et al. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70134 · Cited by 3
Self-citationPrimary biliary cholangitis: assessment and management strategies
Abbas, S. N., Jones, D. E., Kallis, Y. N., Maher, L., & Patanwala, I. (2021) · Gastrointestinal Nursing · doi:10.12968/gasn.2021.19.sup4.s1 · Cited by 3
Self-citationKimura, N., Takahashi, K., Setsu, T., Goto, S., Miida, S., Takeda, N., Kojima, Y., Arao, Y., Hayashi, K., Sakai, N., et al. (2023) · JGH Open · doi:10.1002/jgh3.12915 · Cited by 3
Wang, H., Li, Y., Pu, X., Liang, X. S., Tang, R., & Ma, X. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02045-z · Cited by 3
Cançado, G. G. L., Gomes, N. M. D. F., Couto, C. A., Cançado, E. L. R., Terrabuio, D. R. B., Villela‐Nogueira, C. A., Braga, M. H., Nardelli, M. J., Faria, L. C., Oliveira, E. M. G., et al. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002744 · Cited by 3
Emerging drugs for the treatment of primary biliary cholangitis
Phaw, N. A., Dyson, J. K., & Jones, D. E. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1751814 · Cited by 3
Self-citationEnsuring timely treatment of patients with primary biliary cholangitis
Marschall, H.-U. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30177-8 · Cited by 2
Labanca, S., Cacciato, V., Borro, P., Marenco, S., Pieri, G., Picciotto, A., Torres, M. C. P., & Giannini, E. G. (2021) · Immuno · doi:10.3390/immuno1040033 · Cited by 2
Self-citationTanaka, A., Leung, P. S. C., Bowlus, C. L., & Gershwin, M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_22 · Cited by 2
(2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44307-4.50044-0 · Cited by 2
Sayar, S. (2021) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2021.95825 · Cited by 2
Rigamonti, C., Benedittis, C. D., Labanca, S., Vanni, E., Morgando, A., Manfredi, G. F., Azzolina, D., Cittone, M. G., Giannini, E. G., Saracco, G. M., et al. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002582 · Cited by 2
Self-citationFloreani, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-65908-0_8 · Cited by 2
Self-citationPrimary Biliary Cholangitis, Liver Transplantation, and Hepatocellular Carcinoma: A Mini-review
Rawashdeh, B., Couillard, A. B., Rawshdeh, A., Aziz, H., Esteban, J. P., & Selim, M. A. (2022) · Gene Expression · doi:10.14218/ge.2022.00016 · Cited by 1
Martins, A., & Levy, C. (2025) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001076 · Cited by 1
Liu, J., Zhang, W., Xu, B., Ren, D., & Zhao, Y. (2025) · Cureus · doi:10.7759/cureus.89942 · Cited by 1
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 2
Ruiu, A., Calabrese, M. P., Meschisi, P., Plebani, R., Maria, B., Lleò, A., & Ronca, V. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106883 · Cited by 1
Self-citationRigopoulou, E. I. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_24 · Cited by 1
Giannini, E. G., Pasta, A., Labanca, S., Pieri, G., Marenco, S., & Torres, M. C. P. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101362 · Cited by 1
Self-citationBeattieR.H.Sturrock, JenniferK.Rogers, RossSadler, BerneFerry, Roberts, C. A., RogerW.Chapman, & Lynch, K. D. (2018) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2018.07.797 · Cited by 1
Saffioti, F., Thorburn, D., & Pinzani, M. (2020) · In clinical practice · doi:10.1007/978-3-030-53736-4_27 · Cited by 1
Self-citationBurke, L., Flack, S., Jones, R. L., Aspinall, R., Thorburn, D., Jones, D. E., Braniff, C., Thain, C., Yeoman, A. D., Leithead, J., et al. (2022) · Cureus · doi:10.7759/cureus.25609 · Cited by 1
Self-citationPrimary Biliary Cholangitis (Formerly Primary Biliary Cirrhosis)
Trivedi, P. J., & Hirschfield, G. M. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch38 · Cited by 1
Self-citationHarms, M. H., van Buuren, H. R., & van der Meer, A. J. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.012 · Cited by 1
Predicting Risk in Primary Biliary Cholangitis
Cho, E. J. (2023) · Gut and Liver · doi:10.5009/gnl230239 · Cited by 1
Dunn, S., Evans, L., Kennedy, C., Wafer, R., Moody, S., Wolstenhulme, F., Burton, E., Konkoth, A. B., Fisher, H., Chadwick, T., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113812
“10 This strategy will allow us to optimise treatment delivery in the higher risk group early on, without over-treating the lower risk patients.”
InfluentialSelf-citationOld and novel prognostic biomarkers in primary biliary cholangitis
Mulinacci, G., Palermo, A., Invernizzi, P., & Carbone, M. (2021) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2021.1927700
Self-citationElastography in Autoimmune Liver Diseases
Cristoferi, L., Carbone, M., & Invernizzi, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-74132-7_7
Self-citationSorda, J. A., Ballerga, E. G., Barreyro, F. J., & Daruich, J. R. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16726
Challenges for diagnosis and treatment of primary biliary cholangitis
Tanaka, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85389-7.00007-7
Reply to: “Ductular reaction is a prognostic factor in primary biliary cholangitis”
Carpino, G., Cardinale, V., & Carbone, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100786
Self-citationPrimary biliary cholangitis: progress and gaps in diagnosis and treatment
Komori, A. (2023) · Kanzo · doi:10.2957/kanzo.64.466
Abulitifu, Y., Maimaiti, M., Zhao, F., Adilijiang, M., Qian, W., & Zhang, Y.-P. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04118-0
Biliary tree stem cell transplantation
Paradiso, S., Cremisini, F., Franchitto, M., Carpino, G., & Cardinale, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00014-9
Self-citationPPAR-Agonisten - etablierte Substanzen und neue Entwicklungen
Herta, T., & Tacke, F. (2025) · Gastro-News · doi:10.1007/s15036-025-3896-8
Qasim, B., Kumari, H., Kashif, S. N., Abbas, S. M. I., Hani, O., Salma, O., Sauleh, A., Adnan, F., Ali, M., Raheem, A., et al. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00464-6
Kyritsi, K., Wu, N., Zhou, T., Carpino, G., Baiocchi, L., Kennedy, L. L., Chen, L., Ceci, L., Meyer, A., Barupala, N. P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26560175
Self-citationKyritsi, K., Wu, N., Zhou, T., Carpino, G., Baiocchi, L., Kennedy, L. L., Chen, L., Ceci, L., Meyer, A., Barupala, N. P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26560181
Self-citationKyritsi, K., Wu, N., Zhou, T., Carpino, G., Baiocchi, L., Kennedy, L. L., Chen, L., Ceci, L., Meyer, A., Barupala, N. P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26560166
Self-citationKyritsi, K., Wu, N., Zhou, T., Carpino, G., Baiocchi, L., Kennedy, L. L., Chen, L., Ceci, L., Meyer, A., Barupala, N. P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26560172
Self-citationKyritsi, K., Wu, N., Zhou, T., Carpino, G., Baiocchi, L., Kennedy, L. L., Chen, L., Ceci, L., Meyer, A., Barupala, N. P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26560169
Self-citationKyritsi, K., Wu, N., Zhou, T., Carpino, G., Baiocchi, L., Kennedy, L. L., Chen, L., Ceci, L., Meyer, A., Barupala, N. P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26560178
Self-citationYang, K., Yang, B., Chen, J., Gao, L., Han, X., Hu, J., Zhang, L., Chen, X., Wang, Q., Zhou, X., et al. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04686-9
Cholestatic Immune-Mediated Diseases Management – Part 2
Mandea, M., & Gheorghe, L. S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016073
Zheng, M., Lei, H., He, H., Huang, Y., Zhu, H., Lin, H., Fu, W., Tai, W., Wang, Y., & yang, J. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-05040-9
AISF practice guidance on the treatment of primary biliary cholangitis: A 2026 update
Aghemo, A., Calvaruso, V., Carbone, M., Cazzagon, N., Cristoferi, L., D’Amato, D., D’Ambrosio, R., Fianchi, F., Germani, G., Giannini, E. G., et al. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.06.019
Self-citationAustrian Society of Gastroenterology and Hepatology (ÖGGH) consensus on primary biliary cholangitis
Halilbasic, E., Tatscher, E., Aigner, E., Burghart, L., Graziadei, I. W., Hametner‐Schreil, S., Hofer, B., Hofer, H., Maieron, A., Mandorfer, M., et al. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-026-02798-6
Metadata
- Authors
- Carbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., Ainsworth, H. F., Heneghan, M. A., Thorburn, D., Bathgate, A., Jones, R., Neuberger, J. M., Battezzati, P. M., Zuin, M., Taylor-Robinson, S., Donato, M. F., Kirby, J., Mitchell-Thain, R., Floreani, A., Sampaziotis, F., Muratori, L., Alvaro, D., Marzioni, M., Miele, L., Marra, F., Giannini, E., Gaudio, E., Ronca, V., Bonato, G., Cristoferi, L., Malinverno, F., Gerussi, A., Stocken, D. D., Cordell, H. J., Hirschfield, G. M., Alexander, G. J., Sandford, R. N., Jones, D. E., Invernizzi, P., Mells, G. F., Thomas, C., Rahman, M., Yapp, T., Lye Ch'ng, C., Harrison, M., Sturgess, R., Galaska, R., Healey, C., Whiteman, J., Czaijkowski, M., Gray, C., Gunasekera, A., Gyawli, P., Premchand, P., Mann, S., Elliott, K., Kapur, K., Watson, A., Foster, G., Trembling, P., Subhani, J., Harvey, R., McCorry, R., Adgey, C., Hobson, L., Mulvaney-Jones, C., Evans, R., Mathialahan, T., Ramanaden, D., Gasem, J., Van Duyvenvoorde, G., Shorrock, C., Seward, K., Southern, P., Tibble, J., Penn, R., Gorard, D., Maiden, J., Damant, R., Palegwala, A., Jones, S., Alexander, G., Mells, G., Sandford, R., Whiteman, J., Dolwani, S., Prince, M., Silvestre, V., Foxton, M., Dungca, E., Mitchison, H., Wheatley, N., Gooding, I., Doyle, H., Karmo, M., Kent, M., Saksena, S., Braim, D., Patel, M., Lord, S., Ede, R., Paton, A., Austin, A., Lancaster, N., Sayer, J., Gibbins, A., Hogben, K., Hovell, C., Fisher, N., Carter, M., Koss, K., Musselwhite, J., Muscariu, F., Piotreowicz, A., McKay, A., Grimley, C., Neal, D., Ting Tan, L., Lim, G., Brighton, J., Foale, C., Ala, A., Saeed, A., Flahive, K., Wood, G., Townshend, P., Ford, C., Brown, J., Kordula, J., Bowles, J., Wilkinson, M., Palmer, C., Ramage, J., Gordon, H., Featherstone, J., Ridpath, J., Ngatchu, T., Levi, S., Shaukat, S., Sadeghian, J., Shidrawi, R., Williams, B., Abouda, G., Jones, S., Duggan, C., Hynes, A., Narain, M., Rees, I., Salam, I., Crossey, M., Taylor-Robinson, S., Brown, A., MacNicol, C., Williams, S., Wilhelmsen, E., Banim, P., Raymode, P., Chilton, A., Das, D., Lee, H.-J., Curtis, H., Heneghan, M., Gess, M., Durant, E., Drake, I., Bishop, R., Davies, M., Jones, R., Aldersley, M., Ncube, N., McNair, A., Srirajaskanthan, R., Sen, S., Casey, R., Bird, G., Mendall, M., Cowley, C., Barnardo, A., Kitchen, P., Yoong, K., Amore, K., Sirdefield, D., Orpe, J., Mathew, R., MacFaul, G., Wrigth, A., Shah, A., Evans, C., Keggans, J., Bird, B., Baxter, G., Saha, S., Pollock, K., Hughes, M., Bramley, P., Grieve, E., Young, K., Fraser, A., Mukhopadhya, A., Ocker, K., Mills, P., Hines, F., Shallcross, C., Wilkins, J., Grellier, L., Campbell, S., Martin, K., Bathgate, A., Innes, C., Shepherd, A., Rushbrook, S., Valliani, T., Przemioslo, R., Fairlamb, H., Macdonald, C., Eastick, A., Metcalf, J., Tanqueray, E., Shmueli, U., Holbrook, B., Davis, A., Browning, J., Naqvi, A., Walker, K., Lee, T., Verheyden, J., Slininger, S., Ryder, S. D., Chapman, R., Collier, J., O'Donnell, D., Stafford, L., Williamson, K., Kent, L., Klass, H., Ninkovic, M., March, L., Cramp, M., Simpson, D., Dickson, C., Sharer, N., Hayes, M., Goggin, P., Quinne, M., Pearson, S., Hoeroldt, B., Jones, L., Wright, A., Booth, J., Loftus, A., Lipscomb, G., Dewhurst, H., Gunter, E., Williams, E., Fouracres, A., Farrington, L., Graves, L., Hussaini, H., Stableforth, B., Marriott, S., Ayres, R., Leoni, M., Burroughs, A., Marshall, E., Thorburn, D., Tyrer, D., Martin, K., Lombard, M., Patanwala, I., Dali-Kemmery, L., Lambourne, V., Maltby, J., Vyas, S., Colley, J., Shinder, B., Singhal, S., Jones, J., Mills, M., Gleeson, D., Carnahan, M., Butterworth, J., Boulton, K., Taylor, N., George, K., Harding, T., Tregonning, J., Douglass, A., Brown, C., Clifford, G., Panter, S., Gocher, D., Shearman, J., Bray, G., Hamilton, M., Butcher, G., Forton, D., Mclindon, J., Curtis, J., Das, D., Shewan, T., Cowan, M., Whatley, G., Nasseri, M., Grover, B., Sivaramakrishnan, N., Ducker, S., Houghton, K., Jones, D., Griffiths, L., Tripoli, S., Pitcher, M., Shpuza, E., White, N., Ghosh, D., Douds, A., Green, M., Brookes, M., Cumlat, L., Wong, V. S., Warner, K., Netherton, K., Mandal, A., Jain, S., Gupta, H., Sanghi, P., Pereira, S., Neuberger, J., Gunson, B., Hirschfield, G., Lim, R. T., Gallagher, S., Clement, D., Brind, A., Watts, G., Mupudzi, M., Wright, M., Gitahi, J., Gordon, F., Gocher, D., Unitt, E., Pateman, H., Batham, S., Delahooke, T., Grant, A., Conder, J., Higham, A., Cox, M., O'Donohoe, L., Currie, L., King, A., Oblak, M., Collins, C., Whalley, S., Quinn, M., Baird, Y., Amey, I., Fraser, J., Li, A., Cotterill, D., Bell, A., Watson, A., Singhal, A., Gee, I., Greer, S., Ang, Y., Ransford, R., Allison, J., Gotto, J., Dyer, S., Sweeting, H., Millson, C., Invernizzi, P., Carbone, M., Cristoferi, L., Bonato, G., Malinverno, F., Bernuzzi, F., Alvaro, D., Labbadia, G., Bragazzi, M. C., Andreone, P., Muratori, L., Azzaroli, F., Floreani, A., Galli, A., Tarocchi, M., Giannini, E., Miele, L., Gasbarrini, A., Grieco, A., Marrone, G., Donato, M. F., Valenti, L., Marra, F., Marzioni, M., Maroni, L., Rigamonti, C., Zuin, M., Battezzati, P. M., & Picciotto, A.
- Affiliations
- University of Rome Tor Vergata (IT)
- University of Cambridge (GB)
- Foro Italico University of Rome (IT)
- Sapienza University of Rome (IT)
- Newcastle University (GB)
- PBC Foundation (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Ospedale San Paolo (IT)
- University of Milano-Bicocca (IT)
- Edinburgh Royal Infirmary (GB)
- Queen Elizabeth Hospital Birmingham (GB)
- Imperial College London (GB)
- St James's University Hospital (GB)
- University of Milan (IT)
- University of Padua (IT)
- Agostino Gemelli University Polyclinic (IT)
- ORCID
- Nardi, Alessandra
- Carpino, Guido
- Cardinale, Vincenzo
- Kirby, John
- Mitchell-Thain, Robert
- Sampaziotis, Fotios
- Gaudio, Eugenio
- Ronca, Vincenzo
- Gerussi, Alessio
- Stocken, Deborah D
- Cordell, Heather J
- Gray, Catherine
- Kapur, Kapil
- Foster, Graham
- Trembling, Paul
- Tibble, Jeremy
- Dolwani, Sunil
- Fisher, Neil
- Ala, Aftab
- Brown, Jonathan
- Wilkinson, Mark
- Palmer, Caroline
- Ramage, John
- Shidrawi, Ray
- Williams, Bronwen
- Jones, Sarah
- Banim, Paul
- Das, Debasish
- Lee, Hye-Jeong
- Aldersley, Mark
- Ncube, Noma
- Cowley, Caroline
- MacFaul, George
- Fraser, Andrew
- Mills, Peter
- Grellier, Leonie
- Campbell, Stewart
- Rushbrook, Simon
- Valliani, Talal
- Przemioslo, Robert
- Lee, Tom
- Ryder, Stephen D
- Chapman, Roger
- Collier, Jane
- Stafford, Lizzie
- Cramp, Matthew
- Hoeroldt, Barbara
- Jones, Linda
- Dewhurst, Hannah
- Burroughs, Andrew
- Patanwala, Imran
- Gleeson, Dermot
- George, Keith
- Harding, Tim
- Clifford, Gayle
- Forton, Daniel
- Cowan, Matthew
- Ghosh, Deb
- Douds, Andrew
- Brookes, Matthew
- Gupta, Hemant
- Gunson, Bridget
- Wright, Mark
- Gordon, Fiona
- Batham, Sally
- Collins, Carole
- Whalley, Simon
- Singhal, Amit
- Ang, Yeng
- Millson, Charles
- Labbadia, Giancarlo
- Bragazzi, Maria Consiglia
- Azzaroli, Francesco
- Galli, Andrea
- Tarocchi, Mirko
- Gasbarrini, Antonio
- Grieco, Antonio
- Marrone, Giuseppe
- Valenti, Luca
- Maroni, Luca
- Rigamonti, Cristina
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 3
- Issue
- 9
- Pages
- 626-634
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- PMC
- PMC6962055
- OpenAlex
- W2883784290
- Semantic Scholar
- cd10e32484b0f06ad9d9e15fe1b21304b3b08b07
- Cited by
- 155
- References
- 26
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 20 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 23 · 2019: 15 · 2018: 4
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet. Gastroenterology & hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (085925)
- NIHR Imperial Biomedical Research Centre
- Intercept Pharmaceuticals
- Birmingham Biomedical Research Centre
- Medical Research Council (MR/L001489/1)
- NIHR Nottingham Biomedical Research Centre
- National Institute for Health and Care Research
- Isaac Newton Trust
- Università degli Studi di Milano-Bicocca
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- primary biliary cirrhosis, ursodeoxycholic acid, alkaline phosphatase, total bilirubin, transaminases, liver biopsy histology, ductular reaction, liver fibrosis, biliary injury, second-line therapy, external validation
- MeSH terms
- Alkaline Phosphatase, Transaminases, Bilirubin, Cholagogues and Choleretics, Decision Support Techniques, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Risk Factors, ROC Curve, Ursodeoxycholic Acid, Linear Models, Treatment Outcome, Age of Onset, Area Under Curve, Time-to-Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review